CN103623175A - Medicinal liquor for treating rheumatic ostealgia - Google Patents
Medicinal liquor for treating rheumatic ostealgia Download PDFInfo
- Publication number
- CN103623175A CN103623175A CN201310684960.XA CN201310684960A CN103623175A CN 103623175 A CN103623175 A CN 103623175A CN 201310684960 A CN201310684960 A CN 201310684960A CN 103623175 A CN103623175 A CN 103623175A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- enzymolysis
- mixture
- caulis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000025747 Rheumatic disease Diseases 0.000 title claims abstract description 15
- 230000000552 rheumatic effect Effects 0.000 title claims abstract description 15
- 206010006002 Bone pain Diseases 0.000 title abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 29
- 102000004190 Enzymes Human genes 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 235000019991 rice wine Nutrition 0.000 claims abstract description 13
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000014101 wine Nutrition 0.000 claims description 22
- 241000271039 Agkistrodon Species 0.000 claims description 12
- 241000208340 Araliaceae Species 0.000 claims description 12
- 241001057584 Myrrha Species 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- 229940088598 enzyme Drugs 0.000 claims description 12
- 235000008434 ginseng Nutrition 0.000 claims description 12
- 239000009286 sanguis draxonis Substances 0.000 claims description 12
- 239000003390 Chinese drug Substances 0.000 claims description 10
- 108010059892 Cellulase Proteins 0.000 claims description 7
- 241001506371 Kadsura Species 0.000 claims description 7
- 241001523405 Limax Species 0.000 claims description 7
- 108091005804 Peptidases Proteins 0.000 claims description 7
- 239000004365 Protease Substances 0.000 claims description 7
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 7
- 241001165494 Rhodiola Species 0.000 claims description 7
- 229940106157 cellulase Drugs 0.000 claims description 7
- 102000038379 digestive enzymes Human genes 0.000 claims description 7
- 108091007734 digestive enzymes Proteins 0.000 claims description 7
- 229940059442 hemicellulase Drugs 0.000 claims description 7
- 108010002430 hemicellulase Proteins 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000002255 enzymatic effect Effects 0.000 abstract 3
- 239000000413 hydrolysate Substances 0.000 abstract 3
- 241000382455 Angelica sinensis Species 0.000 abstract 2
- 241000272079 Bungarus multicinctus Species 0.000 abstract 2
- 241000405414 Rehmannia Species 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 9
- 230000036407 pain Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 210000000323 shoulder joint Anatomy 0.000 description 2
- 206010002027 Amyotrophy Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides medicinal liquor for treating rheumatic ostealgia. The medicinal liquor is prepared in the following steps of: (1) according to a prescription, weighing raw materials comprising the following components in parts by mass: 15-25 parts of bungarus multicinctus blyth, 20-30 parts of angelica sinensis, 10-15 parts of radix aconiti kusnezoffii, 25-35 parts of prepared rehmannia root and the like; (2) mixing and crushing the following 23 raw materials including bungarus multicinctus blyth, angelica sinensis, radix aconiti kusnezoffii prepared rehmannia root and the like; (3) adding the traditional Chinese medicine mixture obtained in step (2) into an enzymatic hydrolysate for enzymolysis for 2-4 hours, wherein the mass ratio of the traditional Chinese medicine mixture to the enzymatic hydrolysate is 1:(10-15), the enzymatic hydrolysate contains 0.5m%-2m% complex enzyme, and the enzymolysis temperature is preferably 36-42 DEG C; (4) drying the mixture subject to enzymolysis at 70-80 DEG C until the water content is 30m%-40m%; and (5) adding borneol into the mixture treated in step (4), then adding rice wine and soaking for 15-30 days under the condition of 35-45 DEG C. The medicinal liquor for treating rheumatic ostealgia provided by the invention has the characteristics of remarkable curative effects and convenience for use and is capable of removing wind-dampness and treating ostealgia.
Description
Technical field
The present invention relates to a kind of Traditional Chinese medicinal liquor, especially relate to a kind of Traditional Chinese medicinal liquor that is used for the treatment of rheumatic ostalgia.
Background technology
Rheumatic ostalgia is a kind of chronic disease, and major lesions is each tissue of joint, and as periosteum, cartilage, muscle etc., this disease is frequently-occurring disease, the lighter's arthralgia, and severe one amyotrophy, has brought serious puzzlement to patient.At present, mostly adopt the method for oral medicine to control the state of an illness, but after patient's long-term taking, often there will be the toxic and side effects such as gastrointestinal upset, and increased patient's psychological burden.Although also have some external antirheumatic medicinal liquors, its drug effect to need to improve at present.
Summary of the invention
The object of the invention is to overcome the deficiency that prior art exists, a kind of medicated wine for the treatment of rheumatic ostealgia is provided, it has and has feature evident in efficacy, easy to use, toxic and side effects is little, and this medicated wine can wind-damp dispelling, control osteodynia.
The present invention is for reaching its object, and the technical scheme of employing is as follows:
Treat a medicated wine for rheumatic ostalgia, described medicated wine adopts following steps preparation:
1) by formula, take raw material, described formula comprises each component of following mass parts: dry 15～25 parts of Agkistrodon, 20～30 parts of Radix Angelicae Sinensis, 10～15 parts of Radix Aconiti Kusnezoffii, 25～35 parts, Radix Rehmanniae Preparata, 20～30 parts of Radix Paeoniae Rubra, 25～35 parts of Radix Rhodiolaes, 25～35 parts of Herba Polygalae Japonicae, 25～35 parts of Myrrhas, 15～25 parts of Sanguis Draxonis, 10～20 parts of Rhizoma Cyperis, 5～15 parts, Radix Glycyrrhizae, 40～60 parts of Radix Flemingiae Philippinensiss, 10～20 parts of Radix seu Folium Gaultheriae Forrestiis, 5～15 parts of Fructus Lyciis, 25～35 parts of Radix Rubiae, 20～30 parts of the Cortexs Eucommiae, 15～25 parts of Radix Zanthoxylis, 10～20 parts of Lignum Sappans, 35～45 parts of Radix Aconitis, 25～35 parts of Caulis Piperis Kadsuraes, 10～20 parts of Caulis Sesamis, 5～15 parts of Radix Ginsengs, 5～10 parts, Cornu Cervi Pantotrichum, 5～10 parts of Borneolum Syntheticums, 3000～4000 parts, rice wine,
2) by following raw material co-grinding: Agkistrodon is dry, Radix Angelicae Sinensis, Radix Aconiti Kusnezoffii, Radix Rehmanniae Preparata, Radix Paeoniae Rubra, Radix Rhodiolae, Herba Polygalae Japonicae, Myrrha, Sanguis Draxonis, Rhizoma Cyperi, Radix Glycyrrhizae, Radix Flemingiae Philippinensis, Radix seu Folium Gaultheriae Forrestii, Fructus Lycii, Radix Rubiae, the Cortex Eucommiae, Radix Zanthoxyli, Lignum Sappan, Radix Aconiti, Caulis Piperis Kadsurae, Caulis Sesami, Radix Ginseng, Cornu Cervi Pantotrichum;
3) Traditional Chinese drug mixture step 2 being obtained joins in enzymolysis solution, and enzymolysis 2～4h, the mass ratio of Traditional Chinese drug mixture and enzymolysis solution is 1:10～15, it contains 0.5～2%(quality described enzymolysis solution) compound enzyme; Hydrolysis temperature is preferably 36～42 ℃;
4) mixture after enzymolysis being dried at 70～80 ℃ to water content is 30～40%(quality);
5) Borneolum Syntheticum is joined in the mixture after step 4 is processed, add afterwards rice wine to soak 15～30 days under 35～45 ℃ of conditions.
Further, described compound enzyme is mixed by cellulase, hemicellulase, protease, Limax digestive enzyme.
Preferably, the cellulase that described compound enzyme is 2:1:2:2 by mass ratio, hemicellulase, protease, Limax digestive enzyme mix.
Preferably, each component that described formula comprises following weight portion: dry 20 parts of Agkistrodon, 25 parts of Radix Angelicae Sinensis, 14 parts of Radix Aconiti Kusnezoffii, 30 parts, Radix Rehmanniae Preparata, 25 parts of Radix Paeoniae Rubra, 30 parts of Radix Rhodiolaes, 30 parts of Herba Polygalae Japonicae, 30 parts of Myrrhas, 20 parts of Sanguis Draxonis, 15 parts of Rhizoma Cyperis, 10 parts, Radix Glycyrrhizae, 50 parts of Radix Flemingiae Philippinensiss, 15 parts of Radix seu Folium Gaultheriae Forrestiis, 10 parts of Fructus Lyciis, 30 parts of Radix Rubiae, 25 parts of the Cortexs Eucommiae, 20 parts of Radix Zanthoxylis, 15 parts of Lignum Sappans, 40 parts of Radix Aconitis, 30 parts of Caulis Piperis Kadsuraes, 15 parts of Caulis Sesamis, 10 parts of Radix Ginsengs, 7 parts, Cornu Cervi Pantotrichum, 10 parts of Borneolum Syntheticums, 3000～4000 parts, rice wine.
Technical scheme of the present invention has following beneficial effect:
Medicated wine of the present invention adopts specific formula to make according to specific preparation method, and in preparation process, after pulverizing, enzymolysis, immersion, the effective ingredient dissolution rate in each raw material is high; And in preparation process, between each component, obtain mixing fully contact, each component is interacted.Under the combined effect of various components, medicated wine of the present invention has good effect at aspects such as relaxing muscles and tendons to promote blood circulation, stopping numbness pains, can play the effect of wind-damp dispelling, alleviation osteodynia.Use medicated wine of the present invention, have no side effect, and can contribute to improve immunity, reach the effect for the treatment of both the principal and secondary aspects of a disease, difficult recurrence.
Medicated wine provided by the invention, its using method is that medicated wine is embrocated to affected part, wipes to illing skin slight fever micro-redly, within 1st, embrocates 3 times.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a medicated wine for rheumatic ostalgia, adopt following steps prepare and obtain:
1) by formula, take raw material, described formula comprises each component of following mass parts: dry 15 parts of Agkistrodon, 20 parts of Radix Angelicae Sinensis, 10 parts of Radix Aconiti Kusnezoffii, 25 parts, Radix Rehmanniae Preparata, 20 parts of Radix Paeoniae Rubra, 25 parts of Radix Rhodiolaes, 25 parts of Herba Polygalae Japonicae, 25 parts of Myrrhas, 15 parts of Sanguis Draxonis, 10 parts of Rhizoma Cyperis, 5 parts, Radix Glycyrrhizae, 40 parts of Radix Flemingiae Philippinensiss, 10 parts of Radix seu Folium Gaultheriae Forrestiis, 5 parts of Fructus Lyciis, 25 parts of Radix Rubiae, 20 parts of the Cortexs Eucommiae, 15 parts of Radix Zanthoxylis, 10 parts of Lignum Sappans, 35 parts of Radix Aconitis, 25 parts of Caulis Piperis Kadsuraes, 10 parts of Caulis Sesamis, 5 parts of Radix Ginsengs, 5 parts, Cornu Cervi Pantotrichum, 5 parts of Borneolum Syntheticums, 3000 parts, rice wine;
2) by following raw material co-grinding: Agkistrodon is dry, Radix Angelicae Sinensis, Radix Aconiti Kusnezoffii, Radix Rehmanniae Preparata, Radix Paeoniae Rubra, Radix Rhodiolae, Herba Polygalae Japonicae, Myrrha, Sanguis Draxonis, Rhizoma Cyperi, Radix Glycyrrhizae, Radix Flemingiae Philippinensis, Radix seu Folium Gaultheriae Forrestii, Fructus Lycii, Radix Rubiae, the Cortex Eucommiae, Radix Zanthoxyli, Lignum Sappan, Radix Aconiti, Caulis Piperis Kadsurae, Caulis Sesami, Radix Ginseng, Cornu Cervi Pantotrichum;
3) Traditional Chinese drug mixture step 2 being obtained joins in enzymolysis solution, and enzymolysis 2h under 40 ℃ of conditions, the mass ratio of Traditional Chinese drug mixture and enzymolysis solution is 1:10, described enzymolysis solution is for containing 0.5%(quality) aqueous solution of compound enzyme; The cellulase that described compound enzyme is 2:1:2:2 by mass ratio, hemicellulase, protease, Limax digestive enzyme mix;
4) mixture after enzymolysis being dried at 70 ℃ to water content is 30%(quality);
5) Borneolum Syntheticum is joined in the mixture after step 4 is processed, add afterwards rice wine to soak 15 days under 35 ℃ of conditions.
Embodiment 2
Treat a medicated wine for rheumatic ostalgia, adopt following steps prepare and obtain:
1) by formula, take raw material, described formula comprises each component of following mass parts: dry 25 parts of Agkistrodon, 30 parts of Radix Angelicae Sinensis, 15 parts of Radix Aconiti Kusnezoffii, 35 parts, Radix Rehmanniae Preparata, 30 parts of Radix Paeoniae Rubra, 35 parts of Radix Rhodiolaes, 35 parts of Herba Polygalae Japonicae, 35 parts of Myrrhas, 25 parts of Sanguis Draxonis, 20 parts of Rhizoma Cyperis, 15 parts, Radix Glycyrrhizae, 60 parts of Radix Flemingiae Philippinensiss, 20 parts of Radix seu Folium Gaultheriae Forrestiis, 15 parts of Fructus Lyciis, 35 parts of Radix Rubiae, 30 parts of the Cortexs Eucommiae, 25 parts of Radix Zanthoxylis, 20 parts of Lignum Sappans, 45 parts of Radix Aconitis, 35 parts of Caulis Piperis Kadsuraes, 20 parts of Caulis Sesamis, 15 parts of Radix Ginsengs, 10 parts, Cornu Cervi Pantotrichum, 10 parts of Borneolum Syntheticums, 4000 parts, rice wine;
2) by following raw material co-grinding: Agkistrodon is dry, Radix Angelicae Sinensis, Radix Aconiti Kusnezoffii, Radix Rehmanniae Preparata, Radix Paeoniae Rubra, Radix Rhodiolae, Herba Polygalae Japonicae, Myrrha, Sanguis Draxonis, Rhizoma Cyperi, Radix Glycyrrhizae, Radix Flemingiae Philippinensis, Radix seu Folium Gaultheriae Forrestii, Fructus Lycii, Radix Rubiae, the Cortex Eucommiae, Radix Zanthoxyli, Lignum Sappan, Radix Aconiti, Caulis Piperis Kadsurae, Caulis Sesami, Radix Ginseng, Cornu Cervi Pantotrichum;
3) Traditional Chinese drug mixture step 2 being obtained joins in enzymolysis solution, and enzymolysis 4h under 40 ℃ of conditions, the mass ratio of Traditional Chinese drug mixture and enzymolysis solution is 1:15, described enzymolysis solution is for containing 2%(quality) aqueous solution of compound enzyme; The cellulase that described compound enzyme is 2:1:2:2 by mass ratio, hemicellulase, protease, Limax digestive enzyme mix;
4) mixture after enzymolysis being dried at 80 ℃ to water content is 40%(quality);
5) Borneolum Syntheticum is joined in the mixture after step 4 is processed, add afterwards rice wine to soak 30 days under 45 ℃ of conditions.Embodiment 3
Treat a medicated wine for rheumatic ostalgia, adopt following steps prepare and obtain:
1) by formula, take raw material, described formula comprises each component of following mass parts: dry 20 parts of Agkistrodon, 25 parts of Radix Angelicae Sinensis, 14 parts of Radix Aconiti Kusnezoffii, 30 parts, Radix Rehmanniae Preparata, 25 parts of Radix Paeoniae Rubra, 30 parts of Radix Rhodiolaes, 30 parts of Herba Polygalae Japonicae, 30 parts of Myrrhas, 20 parts of Sanguis Draxonis, 15 parts of Rhizoma Cyperis, 10 parts, Radix Glycyrrhizae, 50 parts of Radix Flemingiae Philippinensiss, 15 parts of Radix seu Folium Gaultheriae Forrestiis, 10 parts of Fructus Lyciis, 30 parts of Radix Rubiae, 25 parts of the Cortexs Eucommiae, 20 parts of Radix Zanthoxylis, 15 parts of Lignum Sappans, 40 parts of Radix Aconitis, 30 parts of Caulis Piperis Kadsuraes, 15 parts of Caulis Sesamis, 10 parts of Radix Ginsengs, 7 parts, Cornu Cervi Pantotrichum, 10 parts of Borneolum Syntheticums, 3000～4000 parts, rice wine;
2) by following raw material co-grinding: Agkistrodon is dry, Radix Angelicae Sinensis, Radix Aconiti Kusnezoffii, Radix Rehmanniae Preparata, Radix Paeoniae Rubra, Radix Rhodiolae, Herba Polygalae Japonicae, Myrrha, Sanguis Draxonis, Rhizoma Cyperi, Radix Glycyrrhizae, Radix Flemingiae Philippinensis, Radix seu Folium Gaultheriae Forrestii, Fructus Lycii, Radix Rubiae, the Cortex Eucommiae, Radix Zanthoxyli, Lignum Sappan, Radix Aconiti, Caulis Piperis Kadsurae, Caulis Sesami, Radix Ginseng, Cornu Cervi Pantotrichum;
3) Traditional Chinese drug mixture step 2 being obtained joins in enzymolysis solution, and enzymolysis 3h under 40 ℃ of conditions, the mass ratio of Traditional Chinese drug mixture and enzymolysis solution is 1:13, described enzymolysis solution is for containing 1.5%(quality) aqueous solution of compound enzyme; The cellulase that described compound enzyme is 2:1:2:2 by mass ratio, hemicellulase, protease, Limax digestive enzyme mix;
4) mixture after enzymolysis being dried at 75 ℃ to water content is 35%(quality);
5) Borneolum Syntheticum is joined in the mixture after step 4 is processed, add afterwards rice wine to soak 20 days under 40 ℃ of conditions.
Application examples:
Zheng, female, 60 years old, suffer from rheumatic arthritis for many years, whenever plum rain season, shoulder and knee joint place hurt like hell.With the medicated wine of embodiment 1, after 2 months, pain is obviously alleviated, and continues to use after 2 months, is meeting Changes in weather, and shoulder and knee joint are not felt pain yet.In use procedure, find no toxic and side effects.
Lee, female 55 years old, suffers from rheumatism joint and aches, and often feels the indistinct pain of extremity, and the pain increased for rainy weather; Use medicated wine pain disappearance after 2 months of embodiment 2, rainy weather pain also alleviates; Adhere to using this medicated wine to fully recover after 7 months, overcast and rainy also feels pain not, finds no toxic and side effects in use procedure.
Lin, man, 60 years old, suffer from rheumatic arthritis, when Changes in weather, general malaise, has a pain in the leg to such an extent that all need to assist on foot, uses 2 months aftersensations of medicated wine of embodiment 3 to take an evident turn for the better; Continue to use after 2 months, then meet Changes in weather, shank is painless, walks also without assisting in, finds no toxic and side effects in use procedure.
The above, it is only preferred embodiment of the present invention, not the present invention is done to any pro forma restriction, the content that does not depart from technical solution of the present invention therefore all, according to technical spirit of the present invention, to any simple modification made for any of the above embodiments, equivalent variations and modification, all still belong in the scope of technical solution of the present invention.
Claims (4)
1. a medicated wine for the treatment of rheumatic ostalgia, is characterized in that, described medicated wine adopts following steps preparation:
1) by formula, take raw material, described formula comprises each component of following mass parts: dry 15～25 parts of Agkistrodon, 20～30 parts of Radix Angelicae Sinensis, 10～15 parts of Radix Aconiti Kusnezoffii, 25～35 parts, Radix Rehmanniae Preparata, 20～30 parts of Radix Paeoniae Rubra, 25～35 parts of Radix Rhodiolaes, 25～35 parts of Herba Polygalae Japonicae, 25～35 parts of Myrrhas, 15～25 parts of Sanguis Draxonis, 10～20 parts of Rhizoma Cyperis, 5～15 parts, Radix Glycyrrhizae, 40～60 parts of Radix Flemingiae Philippinensiss, 10～20 parts of Radix seu Folium Gaultheriae Forrestiis, 5～15 parts of Fructus Lyciis, 25～35 parts of Radix Rubiae, 20～30 parts of the Cortexs Eucommiae, 15～25 parts of Radix Zanthoxylis, 10～20 parts of Lignum Sappans, 35～45 parts of Radix Aconitis, 25～35 parts of Caulis Piperis Kadsuraes, 10～20 parts of Caulis Sesamis, 5～15 parts of Radix Ginsengs, 5～10 parts, Cornu Cervi Pantotrichum, 5～10 parts of Borneolum Syntheticums, 3000～4000 parts, rice wine,
2) by following raw material co-grinding: Agkistrodon is dry, Radix Angelicae Sinensis, Radix Aconiti Kusnezoffii, Radix Rehmanniae Preparata, Radix Paeoniae Rubra, Radix Rhodiolae, Herba Polygalae Japonicae, Myrrha, Sanguis Draxonis, Rhizoma Cyperi, Radix Glycyrrhizae, Radix Flemingiae Philippinensis, Radix seu Folium Gaultheriae Forrestii, Fructus Lycii, Radix Rubiae, the Cortex Eucommiae, Radix Zanthoxyli, Lignum Sappan, Radix Aconiti, Caulis Piperis Kadsurae, Caulis Sesami, Radix Ginseng, Cornu Cervi Pantotrichum;
3) Traditional Chinese drug mixture step 2 being obtained joins in enzymolysis solution, and enzymolysis 2～4h, the mass ratio of Traditional Chinese drug mixture and enzymolysis solution is 1:10～15, it contains 0.5～2%(quality described enzymolysis solution) compound enzyme;
4) mixture after enzymolysis being dried at 70～80 ℃ to water content is 30～40%(quality);
5) Borneolum Syntheticum is joined in the mixture after step 4 is processed, add afterwards rice wine to soak 15～30 days under 35～45 ℃ of conditions.
2. the medicated wine for the treatment of rheumatic ostalgia according to claim 1, is characterized in that, described compound enzyme is mixed by cellulase, hemicellulase, protease, Limax digestive enzyme.
3. the medicated wine for the treatment of rheumatic ostalgia according to claim 1, is characterized in that, the cellulase that described compound enzyme is 2:1:2:2 by mass ratio, hemicellulase, protease, Limax digestive enzyme mix.
4. the medicated wine for the treatment of rheumatic ostalgia according to claim 1, it is characterized in that, each component that described formula comprises following weight portion: dry 20 parts of Agkistrodon, 25 parts of Radix Angelicae Sinensis, 14 parts of Radix Aconiti Kusnezoffii, 30 parts, Radix Rehmanniae Preparata, 25 parts of Radix Paeoniae Rubra, 30 parts of Radix Rhodiolaes, 30 parts of Herba Polygalae Japonicae, 30 parts of Myrrhas, 20 parts of Sanguis Draxonis, 15 parts of Rhizoma Cyperis, 10 parts, Radix Glycyrrhizae, 50 parts of Radix Flemingiae Philippinensiss, 15 parts of Radix seu Folium Gaultheriae Forrestiis, 10 parts of Fructus Lyciis, 30 parts of Radix Rubiae, 25 parts of the Cortexs Eucommiae, 20 parts of Radix Zanthoxylis, 15 parts of Lignum Sappans, 40 parts of Radix Aconitis, 30 parts of Caulis Piperis Kadsuraes, 15 parts of Caulis Sesamis, 10 parts of Radix Ginsengs, 7 parts, Cornu Cervi Pantotrichum, 10 parts of Borneolum Syntheticums, 3000～4000 parts, rice wine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310684960.XA CN103623175B (en) | 2013-12-13 | 2013-12-13 | A kind of medicated wine for the treatment of rheumatic ostalgia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310684960.XA CN103623175B (en) | 2013-12-13 | 2013-12-13 | A kind of medicated wine for the treatment of rheumatic ostalgia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103623175A true CN103623175A (en) | 2014-03-12 |
| CN103623175B CN103623175B (en) | 2016-04-27 |
Family
ID=50204858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310684960.XA Expired - Fee Related CN103623175B (en) | 2013-12-13 | 2013-12-13 | A kind of medicated wine for the treatment of rheumatic ostalgia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103623175B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055728A (en) * | 2015-09-01 | 2015-11-18 | 齐然 | Chinese herb composition for treating rheumatism |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101406584A (en) * | 2008-11-27 | 2009-04-15 | 蒋月芝 | Agent for treating gout |
| CN102872301A (en) * | 2012-08-15 | 2013-01-16 | 邓水苟 | Anti-rheumatism medicinal liquor and using method thereof |
-
2013
- 2013-12-13 CN CN201310684960.XA patent/CN103623175B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101406584A (en) * | 2008-11-27 | 2009-04-15 | 蒋月芝 | Agent for treating gout |
| CN102872301A (en) * | 2012-08-15 | 2013-01-16 | 邓水苟 | Anti-rheumatism medicinal liquor and using method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055728A (en) * | 2015-09-01 | 2015-11-18 | 齐然 | Chinese herb composition for treating rheumatism |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103623175B (en) | 2016-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102920984B (en) | Medicine for curing rheumatoid arthritis | |
| CN103623200B (en) | A kind of Chinese medicine composition preventing and treating bamboo rat cold | |
| CN103656025B (en) | A kind of medical liquor for treating injury | |
| CN104491052A (en) | Traditional Chinese medicine composition for treating rheumatic and rheumatoid arthritis and preparation method thereof | |
| CN103690734B (en) | A kind of antirheumatic medicinal liquor | |
| CN100522222C (en) | Plaster for treating cough in children | |
| CN103623175B (en) | A kind of medicated wine for the treatment of rheumatic ostalgia | |
| CN102872301A (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN102961539B (en) | Plaster for treating wind-cold-dampness arthralgia and preparation method thereof | |
| CN102048935A (en) | Formula of traditional Chinese medicine for treating chronic rhinitis | |
| CN105456980A (en) | Antipyretic patch for treating winter cold and fever and preparation method of antipyretic patch | |
| CN105641659A (en) | Traditional Chinese medicine formula for treating arthralgia and myalgia | |
| CN105616966A (en) | Traditional Chinese medicine for treating arthritis | |
| CN109394891A (en) | A kind of plaster preparation process | |
| CN103638402A (en) | Internal medicinal liquor for treating traumatic injuries and preparation method thereof | |
| CN103316203B (en) | Externally applied traditional Chinese medicine for treating sprain | |
| CN107375455A (en) | A kind of anti-inflammatory is reduced internal heat Chinese herbs paste | |
| CN102755609B (en) | Plaster for treating bronchitis | |
| CN106692927A (en) | Medicinal liquor for treating rheumatism | |
| CN103623170A (en) | Healthcare medicinal liquor | |
| CN104491818A (en) | Formula for treating rheumatoid rheumatic arthritis and preparation method thereof | |
| CN105169262A (en) | Traditional Chinese medicine formula for bone-fracture postoperative recovery nursing | |
| CN104138501A (en) | Traditional Chinese medicine for treating parasitic orchitis | |
| CN103142777A (en) | Yang-strengthening pill | |
| CN103989964A (en) | Externally-applied medicine for treatment of neck, shoulder, waist and leg pain and sprain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ma Honggang Inventor before: Dai Nvbian |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20171020 Address after: 253200 No. 43 civilized street, Xiajin County, Dezhou, Shandong Patentee after: Ma Honggang Address before: Xinhui District, Guangdong city of Jiangmen province Longji village 529153 double water village 117 town of Longnan Patentee before: Dai Nvbian |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181019 Address after: 100071 Beijing Fengtai District East blacksmith battalion horizontal 31 No. 6 Building 3 floor 0319. Patentee after: Beijing Zhong run Qi source Biotechnology Co., Ltd. Address before: 253200 43 civilized street, Xiajin County, Dezhou, Shandong Patentee before: Ma Honggang |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181123 Address after: 100071 Beijing Fengtai District Science City, Haiying Road, 9 building 9-6, 1, 2, 208 rooms. Patentee after: China run National Power Group Limited Address before: 100071 Beijing Fengtai District East blacksmith battalion horizontal 31 No. 6 Building 3 floor 0319. Patentee before: Beijing Zhong run Qi source Biotechnology Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160427 Termination date: 20191213 |